A New Estimate of Drug Development Cost
Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'
Fair Social Media Practice Principles
Rules for Third-Party Engagement in Patient/Physician Social Networks. A Social Media Policy is not just an agreement that users must abide by. More importantly, it is a PROMISE to users from site owners/sponsors concerning how they will protect or attempt to protect user-generated content, personal conversations, interactions, and engagements with third-parties on the site. These policies should comply with as-yet-to-be-determined, universally accepted 'fair social media practice principles.'
PhRMA Masters the Art of “Proofiness!”
In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry.
Pharma Marketing News Vol. 10, No. 14: 22 September 2011
Welcome to Volume 10, Issue #14 (22 SEPTEMBER 2011) of Pharma Marketing News.
Finding the Consumer Within the Patient: Insights Into How Healthcare Decisions are Made
Self Care Catalysts' Patient Intelligence Insights Guide™ on Diabetes is the only integrated patient-and consumer-centric report that explores how people suffering from an invisible condition such as diabetes actually circumnavigate their health condition, using the unique Self Care Health Decision Making Dynamics framework™. It is an example of what Grace Soyao, Founder & Chief Strategy Officer of Self Care Catalysts Inc., a health research and strategy company, means by 'Finding the Consumer within the Patient.'
Is There an Upward Career Path for Pharma Social Media Pioneers?
Are we witnessing an exodus of social media
Implications of Facebook’s Page Commenting Changes
A discussion with Jonathan Richman, Group Director, Insights and Planning at Possible Worldwide about Facebook's changes to its commenting policies and his recommendations for pharma marketers who wish to develop Facebook pages.
Pharma Marketing News Vol. 10, No. 9: 18 May 2011
Welcome to Volume 10, Issue #9 (18 MAY 2011) of Pharma Marketing News.
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
Pharma Marketing News Vol. 10, No. 9: 18 May 2011
Welcome to Volume 10, Issue #9 (18 MAY 2011) of Pharma Marketing News.
